Small Business Innovation Research · Small Business Technology Transfer
Myogenica Inc.: SBIR & STTR awards
2 awards worth $1.56M to 1 companies since 2023 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Myogenica Inc.'s federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2025 | 0 | 1 | $1.27M |
| 2023 | 1 | 0 | $292.7K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD · topic NIAMS | Myogenica Inc. · Minnesota | Department of Health and Human Services · National Institutes of Health | STTR Phase II | $1.27M | 2025-09-24 |
| Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD · topic NIAMS | Myogenica Inc. · Minnesota | Department of Health and Human Services · National Institutes of Health | STTR Phase I | $292.7K | 2023-09-25 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.